← Back to Search

EMLA for Lymphoma

Phase 4
Waitlist Available
Led By Mohamad Badawi, MD
Research Sponsored by CAMC Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up , pain will be assessed at 30 - 60 minutes after waking up after lumbar puncture and 24 hours after lumbar puncture
Awards & highlights

Study Summary

This trial will compare whether numbing the skin before a spinal tap with EMLA cream or injecting lidocaine numbs the area better and causes less pain for children being treated for leukemia or lymphoma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~, pain will be assessed at 30 - 60 minutes after waking up after lumbar puncture and 24 hours after lumbar puncture
This trial's timeline: 3 weeks for screening, Varies for treatment, and , pain will be assessed at 30 - 60 minutes after waking up after lumbar puncture and 24 hours after lumbar puncture for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post Lumbar Puncture Pain: Wong-Baker Faces Pain Rating Scale
Secondary outcome measures
Post Lumbar Puncture PRN Pain Medication Usage

Trial Design

2Treatment groups
Active Control
Group I: EMLAActive Control1 Intervention
The patient will receive 5 grams EMLA cream at the site of the lumbar puncture at least 60 minutes prior to procedure. The site of EMLA application will be covered with Tegaderm dressing.
Group II: LidocaineActive Control1 Intervention
The patient will receive sham-EMLA cream (a fragrance-free hypoallergenic moisturizer cream) will be applied at least 60 minutes per standard protocol with Tegaderm dressing.- Following conscious sedation, the patient will receive lidocaine 1% injection (~1-2ml) at the appropriate site 30-60 seconds prior to LP needle insertion.

Find a Location

Who is running the clinical trial?

CAMC Health SystemLead Sponsor
45 Previous Clinical Trials
8,056 Total Patients Enrolled
Mohamad Badawi, MD4.04 ReviewsPrincipal Investigator - WVU-Charleston and CAMC
CAMC Health System
5Patient Review
Dr Badawi was incredibly patient with my 3 year old. His illustrations were easy to interpret and very helpful.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures
Mohamad Badawi, MD 2019. "Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04003012.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top